• Explore /
  • Poster
  • / A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Abstract Poster

Authors

null

Nicholas James Short

The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX

Nicholas James Short , Hagop M. Kantarjian , Marina Konopleva , Guillermo Montalban Bravo , Farhad Ravandi , Nitin Jain , Tapan M. Kadia , Yesid Alvarado Valero , Kelly Sharon Chien , Naval Guastad Daver , Walid Macaron , Koji Sasaki , Jennifer Thankachan , Ricardo Delumpa , Ejiroghene Mayor , Wuliamatu Deen , Christopher Loiselle , Monica Kwari , Rebecca Garris , Elias Jabbour

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT03263572

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7009)

DOI

10.1200/JCO.2022.40.16_suppl.7009

Abstract #

7009

Poster Bd #

240

Abstract Disclosures

Similar Posters

First Author: Nicholas James Short

First Author: Yago Nieto

First Author: Jing Pan

First Author: Niloufer Khan